The Waters Difference: Building Quality into Everything We Do – From A to Z
Waters difference is building quality into every step of the process. Everything we do is focused on making sure our customers receive high quality products, on time.
Safeguard HPLC Data Quality with Planned Performance Maintenance
Reproducible, accurate data is critical for making key decisions about your products and obtaining important insights into your research. Learn how to safeguard your data quality by ensuring your HPLC instrument remains consistently in peak condition.
Oligonucleotide Manufacturers Keep up with Market Demand using Our Compliance-Ready Instruments
Recent developments in techniques for rapid and efficient oligonucleotide synthesis and molecular biology technology have expanded the market for manufacturers and service providers in the field. Liquid chromatography coupled with mass spectrometry (LC-MS) workflows play a critically important role.
![Attribute Monitoring Workflows [Infographic]](https://www.waters.com/blog/wp-content/uploads/feature-image-768x758.png.webp)
Attribute Monitoring Workflows [Infographic]
Learn how the BioAccord LC-MS System is instrumental in the drug development workflow from sample prep to reporting.
Modern Perspectives on Method Development
Hear from Dr. Fadi Alkhateeb, a Waters Senior Separations Scientist on the approach and tools used to design and develop fit-for-purpose methods.
BioAccord System with ACQUITY Premier: Some Things Work Better Together
Combining BioAccord, our most capable MS detection platform, with ACQUITY Premier UPLC, our highest performance LC system, to demonstrate superior performance.
Reliable, Reportable Data with Analytical Quality by Design Approaches
The ways pharmaceutical organizations achieve reliable, reportable data is shifting. We discuss how leveraging modern analytical tools and applying an Analytical Quality by Design approach in your lab can increase the robustness of analytical methods.
Biopharma’s Future: Next-Generation LC-MS Workflows for Peptide MAM
The development of biotherapeutics continues to accelerate with their potential to revolutionize disease treatment in areas not adequately addressed by small molecule therapeutics. However, the complexity of these macromolecules and the range of potential modification variants (attributes) creates an interesting analytical challenge for scientists tasked with their characterization and then with monitoring those attributes important…
Embracing Analytical Techniques Into Regulated Laboratories
To ensure compliance success in a changing regulatory landscape, laboratories must continually adapt. Learn how the compliant-ready Waters BioAccord LC-MS platform helps biopharma address the additional compliance challenges posed by the field’s complex analytical instruments.
Comprehending COVID-19: How Consumables Can Increase LC-MS/MS Sensitivity
During 2020, we collaborated with many of our customers to develop targeted liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) methods to detect SARS-CoV-2 (the virus that causes COVID-19) from biological samples. However, the combination of the biological specimen, the sample collection medium, the viral load threshold, and the need for a high throughput method gave rise to…
Answering the Call with Compliance-Ready LC-MS Solutions for Oligonucleotide Analysis
Oligonucleotides, or short strands of DNA or RNA, continue to increase in popularity. In addition to their essential role as primers and probes in the expanding clinical DNA testing and diagnostics market, they’re also seeing great success as new gene-based therapeutics that hold tremendous promise. With a string of recent drug approvals, including the first…
Boosting Biopharma Productivity with Routine LC-MS
As scientific advances continue to carry researchers into new arenas, it is vital that technology evolves in tandem. At Waters, we understand that it is only by leveraging fit-for-purpose technologies that researchers are able to unleash their creativity and make pioneering scientific breakthroughs. Scientists working within the rapidly growing biopharmaceutical industry are no exception. With…